Search research articles
Contact Us
Filters
Showing results (91-100 of 235) with videos related to
Page
of 24
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation
Charles M Rudin, David Balli, W Victoria Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer
Kathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
J C Osorio, A Ni, J E Chaft, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
Jia Luo, Jason A Beattie, Paige Fuentes, et al.
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
Helena A Yu, Ken Suzawa, Emmet Jordan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
Maria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L Derosa, M D Hellmann, M Spaziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers
Michael Offin, Hira Rizvi, Megan Tenet, et al.
Page
of 24
Search research articles
Search
Showing results (91-100 of 235) with videos related to
Sort By:
Page
of 24
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation
Charles M Rudin, David Balli, W Victoria Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer
Kathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
J C Osorio, A Ni, J E Chaft, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
Jia Luo, Jason A Beattie, Paige Fuentes, et al.
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
Helena A Yu, Ken Suzawa, Emmet Jordan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
Maria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L Derosa, M D Hellmann, M Spaziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers
Michael Offin, Hira Rizvi, Megan Tenet, et al.
Page
of 24